Riskpilot← Back to searchSign inGet full accessEuroform MediPharm AB
ABActiveOrg 5568728298Vickerkullavägen 6Manufacture of other plastic products · NACE 2226Est. 201111 employees
Revenue 2024
SEK 28,5M
-11% vs 2023
EBITDA margin
-6.9%
-280% vs 2023
Equity ratio
68.9%
Financial strength
Net profit 2024
SEK 233K
+38% vs 2023
| Revenue | SEK 28,5M | -11% |
| EBITDA | SEK -2M | -280% |
| Net profit | SEK 233K | +38% |
| Total assets | SEK 20,5M | -15% |
| Equity | SEK 14,1M | +2% |
| Employees | 11 | — |
Legal name
Euroform MediPharm AB
Org number
5568728298
Legal form
Aktiebolag
NACE code
2226 · Manufacture of other plastic products
Founded
22 november 2011
Share capital
SEK 100 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall bedriva tillverkning och utveckling av polymera systemlösningar för formsprutning av plastkomponenter till medicinsk- och högteknologisk industri, samt idka därmed förenlig verksamhet.
Address
Vickerkullavägen 6
Phone
+46140384900
Email
johan.wahlstrom@euroform.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 29 070 | 35 608 | 35 802 | 31 899 | 28 526 |
| Staff expenses | — | — | — | — | — |
| EBITDA | −937 | −4 611 | −2 573 | 1 091 | −1 969 |
| Depreciation & amort. | −2 011 | −6 942 | −879 | −878 | −670 |
| EBIT | −2 948 | −11 553 | −3 452 | 213 | −2 639 |
| Net financials | −310 | −390 | −78 | 272 | 237 |
| Profit before tax | 1 | −33 | 62 | 169 | 233 |
| Tax | −0 | −0 | −0 | −0 | −0 |
| Net profit | 1 | −33 | 62 | 169 | 233 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 25 636 | 27 589 | 24 763 | 24 143 | 20 519 |
| Equity | 13 714 | 13 681 | 13 743 | 13 912 | 14 145 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 7 426 | 11 783 | 9 400 | 9 481 | 5 625 |
| Total debt | 7 426 | 11 783 | 9 400 | 9 481 | 5 625 |
EBITDA margin
-6.9%
This company
15.8%
Market median
-144% vs market
20202024
Equity ratio
68.9%
This company
38.2%
Market median
+80% vs market
20202024
Return on equity
1.6%
This company
18.4%
Market median
-91% vs market
20202024
Net profit margin
0.8%
This company
8.1%
Market median
-90% vs market
20202024
Asset turnover
1.39×
This company
1.12×
Market median
+24% vs market
20202024
Debt / equity
0.45×
This company
0.62×
Market median
+27% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
GE Chief Auditor | Chief Auditor | 2021 |
JP Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (3) | ||
SJ Chief Executive Officer | Chief Executive Officer | 2022 – 2022 |
KH Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
MJ Chief Executive Officer | Chief Executive Officer | 2021 – 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Deputy Board Member | 2026 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Vätterleden Holding AktiebolagVätterledens Invest AktiebolagAktiebolaget Euroform
Euroform MediPharm AB (this company)Board members of Euroform MediPharm AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Gunnar Erik Kristoffer Johansson | Chief Auditor | 0 companies |
| Johan Peter Wahlström | Chief Executive Officer | 0 companies |
| Stig Jörgen Mansner | Chief Executive Officer | 0 companies |
| Karl Henrik Andreas Dufvall | Chief Executive Officer | 0 companies |
| Mikko Juhani Sorjonen | Chief Executive Officer | 0 companies |
| Jens Karl Lars Fredriksson | Deputy Board Member | 0 companies |